Randomised double masked trial comparing the efficacy and tolerance of 0.05% mequitazine eye drops versus 0.05% levocabastine and placebo in allergic conjunctivitis induced by a conjunctival provocation test with Dermatophagoides pteronyssinus.
D000293:Adolescent; D000328:Adult; D016009:Chi-Square Distribution; D003233:Conjunctivitis, Allergic / Q000188:drug therapy* / Q000469:parasitology; D040002:Dermatophagoides pteronyssinus; D004311:Double-Blind Method; D005260:Female; D006634:Histamine H1 Antagonists / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009883:Ophthalmic Solutions; D010640:Phenothiazines / Q000008:administration & dosage*; D010880:Piperidines / Q000008:administration & dosage*; D018709:Statistics, Nonparametric
D006634:Histamine H1 Antagonists; D009883:Ophthalmic Solutions; D010640:Phenothiazines; D010880:Piperidines; C047340:levocabastine; C006069:mequitazine